These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 17615152

  • 1. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
    Cheng J, Zhang C, Shapiro DJ.
    Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
    Cheng J, Yu DV, Zhou JH, Shapiro DJ.
    J Biol Chem; 2007 Oct 19; 282(42):30535-43. PubMed ID: 17716978
    [Abstract] [Full Text] [Related]

  • 3. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 19; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 4. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
    Castro-Rivera E, Safe S.
    J Steroid Biochem Mol Biol; 2003 Jan 19; 84(1):23-31. PubMed ID: 12648521
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT.
    Mol Endocrinol; 2004 Dec 19; 18(12):2908-23. PubMed ID: 15345745
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
    Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Khosla S, Spelsberg TC.
    Mol Endocrinol; 2005 Jun 19; 19(6):1555-68. PubMed ID: 15802376
    [Abstract] [Full Text] [Related]

  • 7. Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.
    Singleton DW, Feng Y, Burd CJ, Khan SA.
    Endocrinology; 2003 Jan 19; 144(1):121-8. PubMed ID: 12488337
    [Abstract] [Full Text] [Related]

  • 8. Classical genotropic versus kinase-initiated regulation of gene transcription by the estrogen receptor alpha.
    Almeida M, Han L, O'brien CA, Kousteni S, Manolagas SC.
    Endocrinology; 2006 Apr 19; 147(4):1986-96. PubMed ID: 16384865
    [Abstract] [Full Text] [Related]

  • 9. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC, Krieg S, Shapiro DJ.
    Mol Endocrinol; 1999 Apr 19; 13(4):632-43. PubMed ID: 10194768
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
    Thomas RS, Sarwar N, Phoenix F, Coombes RC, Ali S.
    J Mol Endocrinol; 2008 Apr 19; 40(4):173-84. PubMed ID: 18372406
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.
    Chen D, Washbrook E, Sarwar N, Bates GJ, Pace PE, Thirunuvakkarasu V, Taylor J, Epstein RJ, Fuller-Pace FV, Egly JM, Coombes RC, Ali S.
    Oncogene; 2002 Jul 25; 21(32):4921-31. PubMed ID: 12118371
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
    Duplessis TT, Williams CC, Hill SM, Rowan BG.
    Endocrinology; 2011 Jun 25; 152(6):2517-26. PubMed ID: 21505052
    [Abstract] [Full Text] [Related]

  • 13. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J, Liu H, Bentrem DJ, Zapf JW, Jordan VC.
    Cancer Res; 2000 Sep 15; 60(18):5097-105. PubMed ID: 11016635
    [Abstract] [Full Text] [Related]

  • 14. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K, Thu N, Saville B, Safe S.
    Mol Endocrinol; 2003 May 15; 17(5):804-17. PubMed ID: 12576490
    [Abstract] [Full Text] [Related]

  • 15. Targeted mutation of key residues at the start of helix 12 in the hERalpha ligand-binding domain identifies the role of hydrogen-bonding and hydrophobic interactions in the activity of the protein.
    Zhao C, Abrams J, Skafar DF.
    J Steroid Biochem Mol Biol; 2006 Jan 15; 98(1):1-11. PubMed ID: 16191480
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
    Arao Y, Hamilton KJ, Coons LA, Korach KS.
    J Biol Chem; 2013 Jul 19; 288(29):21105-21116. PubMed ID: 23733188
    [Abstract] [Full Text] [Related]

  • 17. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 19; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 18. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V, Gougelet A, Maillard S, Renoir JM.
    Mol Endocrinol; 2003 Oct 19; 17(10):2013-27. PubMed ID: 12855746
    [Abstract] [Full Text] [Related]

  • 19. Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.
    Huderson BP, Duplessis TT, Williams CC, Seger HC, Marsden CG, Pouey KJ, Hill SM, Rowan BG.
    Endocrinology; 2012 Sep 19; 153(9):4144-59. PubMed ID: 22733972
    [Abstract] [Full Text] [Related]

  • 20. Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes.
    Schwartz JA, Liu G, Brooks SC.
    Biochem Biophys Res Commun; 1998 Dec 09; 253(1):38-43. PubMed ID: 9875216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.